CNP and schizophrenia: A number of studies have recently been carried out on transgenic mice to clarify the role of CNP. Lappe-Siefke et al. showed that CNP-deficient mice displayed a reduction in overall brain size, enlarged ventricles and corpus callosum atrophy, features which were also observed in schizophrenia patients[8].